Anti-TMPRSS2 antibodies and antigen-binding fragments
US11999799B2 · kind B2 · utility
0Cited by
12References
44Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 9, 2021 |
| Grant date | Jun 4, 2024 |
| Priority date | — |
| Expiry date | Apr 24, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides antibodies and antigen-binding fragments thereof that bind specifically to TMPRSS2 and methods of using such antibodies and fragments for treating or preventing viral infections (e.g., coronavirus infections or influenza virus infections).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.